Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2020 $ (198,525) $ 399 $ 505,762 $ (703,164) $ (1,522)
Beginning balance (in shares) at Mar. 31, 2020   39,905,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (17,997)     (17,997)  
Foreign currency translation adjustments, net 1,984       1,984
Shares issued under employee stock purchase plan 539 $ 2 537    
Shares issued under employee stock purchase plan (in shares)   133,000      
Shares issued under employee incentive plans, net 0 $ 12 (12)    
Shares issued under employee stock incentive plans, net (in shares)   1,155,000      
Shares issued in connection with business acquisition 2,080 $ 3 2,077    
Shares issued in connection with business acquisition (in shares)   361,000      
Warrants issued related to long-term debt 11,515   11,515    
Stock-based compensation 6,428        
Ending balance at Dec. 31, 2020 (193,976) $ 416 526,307 (721,161) 462
Ending balance (in shares) at Dec. 31, 2020   41,554,000      
Beginning balance at Sep. 30, 2020 (196,240) $ 408 522,357 (718,492) (513)
Beginning balance (in shares) at Sep. 30, 2020   40,740,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (2,669)     (2,669)  
Foreign currency translation adjustments, net 975       975
Shares issued under employee stock purchase plan 0 $ 5 (5)    
Shares issued under employee stock purchase plan (in shares)   453,000      
Shares issued under employee incentive plans, net 2,080 $ 3 2,077    
Shares issued under employee stock incentive plans, net (in shares)   361,000      
Stock-based compensation 1,878   1,878    
Ending balance at Dec. 31, 2020 (193,976) $ 416 526,307 (721,161) 462
Ending balance (in shares) at Dec. 31, 2020   41,554,000      
Beginning balance at Mar. 31, 2021 $ (112,245) $ 570 626,664 (738,623) (856)
Beginning balance (in shares) at Mar. 31, 2021 56,915,000 56,915,000      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (24,466)     (24,466)  
Foreign currency translation adjustments, net (276)       (276)
Shares issued under employee stock purchase plan 806 $ 1 805    
Shares issued under employee stock purchase plan (in shares)   145,000      
Shares issued under employee incentive plans, net 0 $ 19 (19)    
Shares issued under employee stock incentive plans, net (in shares)   1,935,000      
Shares issued in connection with business acquisition 2,818 $ 9 2,809    
Shares issued in connection with business acquisition (in shares)   821,000      
Stock-based compensation 10,580   10,580    
Ending balance at Dec. 31, 2021 $ (122,783) $ 599 640,839 (763,089) (1,132)
Ending balance (in shares) at Dec. 31, 2021 59,816,000 59,816,000      
Beginning balance at Sep. 30, 2021 $ (115,993) $ 593 636,538 (752,029) (1,095)
Beginning balance (in shares) at Sep. 30, 2021   59,272,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (11,060)     (11,060)  
Foreign currency translation adjustments, net (37)       (37)
Shares issued under employee stock purchase plan 0 $ 0 0    
Shares issued under employee stock purchase plan (in shares)   0      
Shares issued under employee incentive plans, net 0 $ 2 (2)    
Shares issued under employee stock incentive plans, net (in shares)   183,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with business acquisition (in shares)   361,000      
Stock-based compensation 4,307   4,307    
Ending balance at Dec. 31, 2021 $ (122,783) $ 599 $ 640,839 $ (763,089) $ (1,132)
Ending balance (in shares) at Dec. 31, 2021 59,816,000 59,816,000